A recent publication by Prof Stricker’s and Prof Emberton’s group in the journal Prostate Cancer and Prostate Diseases confirmed the safety of NanoKnife focal therapy in prostate cancer. Prof Stricker feels that this is a major advance in focal therapy as irreversible electroporation has significant potential advantages over all the other energy sources currently used […]
The ABC recently reported on the use of MRI in testing for prostate cancer. The story focusses on the St Vincent’s study that looked at 150 men over the age of 40 with positive PSA tests. The average age was 62 years old and they all had MRI scans. Professor Phillip Stricker authored the study and
MRI scans could be a ‘game-changer’ in prostate cancer testing Read More »
Prof Stricker now has perfected the technique of MR-ultrasound fusion biopsies using the safe transperineal technique but using the technology of MRI’s for accurate localisation. Using the Biojet system, Prof Stricker has perfected he technique of MR-ultrasound fusion biopsies, having now performed over 100. He confirmed that the MRI allows for accurate localisation. The procedure is
Accuracy and safety of MRI/US targeted biopsies confirmed Read More »
Dr Stricker’s research group has recently published research on the outcomes of patients having MRI prior to biopsy. It was proven that the approach was very useful and the technology was dependable and highly accurate. They found that if the MRI was clear, there was a 97% chance of not having a significant cancer. If
The value of MRI before biopsy Read More »
Prof Stricker and his team at St Vincent’s is now offering Choline Pet/CT Scans. Shortly be opening a trial to look at PSMA scanning to be able to more accurately localise metastatic prostate cancer. He considers this a revolution in the assessment of prostate cancer spread. Further, it will enable the tailoring of therapies according
Choline & PSMA scans to assess extent of prostate cancer Read More »
Focal Nanoknife therapy for localised prostate cancer is proving to be a safe treatment. Although relatively new Prof Stricker has now completed over 35 focal NanoKnife treatments and is extremely pleased with the safety. Less than 10% were unsuccessful and most could be retreated .The recent publication where he combined his data with the English group,
Focal Nanoknife therapy – safe new treatment Read More »
Jill Margo’s article in the Financial Review, “Experience trumps tehnique when it comes to surgery“, looks at the recent study published in European Urology that focussed on Dr Stricker’s results.
Experience trumps technique when it comes to surgery Read More »
Australia’s first targeted safe biopsy of the prostate. Prof Stricker is amongst the first in Australia to pursue transperineal MRI ultrasound-fusion guided biopsy into the prostate. This uses advances in MRI imaging, fused with ultrasound. He recently confirmed that this was the safest biospy technique. Prof Stricker went on to say that the MRI ultrasound-fusion
MRI Guided transperineal biopsy Read More »
After having completed 250 cases where MRI’s were performed before biopsies on patients with raised PSA, the study concluded that if the MRI is negative, it is highly accurate. This suggests that perhaps one can avoid biopsies in this situation. Furthermore if the MRI is positive, it also improves the accuracy of targeting the tumour.
MRI as a second-line screening tool Read More »
The St Vincent’s Prostate Support Group makes its much needed return on Tuesday the 22nd of October between 7 and 9pm. The group meets at the Clinic Function Room (Level 4 St Vincent’s Clinic) 438 Victoria Street, Darlinghurst. Car parking available at the Clinic carpark – enter via Barcom Avenue. For more information please call
The St Vincent’s Prostate Support Group returns Read More »
Prof Stricker has now taken up the clinical directorship of the Australian Prostate Cancer Research Centre in New South Wales. He is also one of the integral members of the National Prostate Cancer Research Centre Australia-wide. The key areas of research that he is looking into are: A. The use of imaging and improved accuracy
Australian Prostate Cancer Research Centre NSW Read More »
Opened late last year by Prime Minister Gillard, The Kinghorn Cancer Centre is a joint venture between the Garvan Institute of Medical Research and St Vincent’s Hospital. Associate Professor Phillip Stricker was appointed Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre. In response to the $5.5 million dollars funding over four years, he
Clinical Director Prostate Cancer Research at The Kinghorn Cancer Centre Read More »
The first case of Nanoknife treatment for prostate cancer was performed in late February. Dr Stricker said he was pleased with the outcome and welcomed a leading edge surgical technology that would allow yet another option when tailoring treatments for patients. In particular, he felt that that the Nanoknife procedure coould help minimise side-effects. Nanoknife
Nanoknife – the first case Read More »
Dr Stricker performed just over 250 surgical cases in 2012, one of the largest series in Australasia. When asked about the breakdown between robotic and open, he said that as per previous years over 200 were robotic. Given the outcomes, he believes it wil continue as a favoured choice for surgical treatment. Dr Stricker has
Robotic surgery prevails Read More »
Prime Minister Julia Gillard, Deputy Prime Minister Wayne Swan and Minister for Health Tanya Plibersek announced Sydney would have a new centre of excellence to research and treat prostate cancer. Located in the newly opened Kinghorn Cancer Centre, this new prostate cancer reasearch facility will be a joint initiative between the Garvan Institue, St
World-class prostate research centre for Sydney Read More »
